Antibody PF-06747143 both attacks AML tumor cells and moves them from the nurturing bone marrow environment into the peripheral blood streams, where they are more vulnerable. Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the nurturing bone marrow environment into the peripheral blood...